Literature DB >> 1968035

Marker haplotype association with growth in German cystic fibrosis patients.

B Tümmler1, A Aschendorff, T Darnedde, K Fryburg, G Maass, J Hundrieser.   

Abstract

In 84 families with 101 children with cystic fibrosis (CF) and 103 unaffected siblings, the haplotype of CF chromosomes was determined with six restriction fragment length polymorphism (RFLP) markers that span the CF gene locus. Patient groups with different genotypes in the more distant flanking marker loci MET D, MET H, and D7S8 differed significantly from each other with respect to percentile height and weight, and percentage of weight for height. Patients homozygous 1-1 in met D (TaqI) and met H (TaqI) were thin and tall when homozygous 1-1 in J3.11 (MspI), and small when homozygous 2-2 in J3.11. Heterozygosity in 3.11 and met H and homozygosity 1-1 in met D segregated with the most severe growth retardation. In contrast, growth was normal in patients who were heterozygous in met D and/or had an uncommon KM.19/XV-2c haplotype. Most patients with pancreatic sufficiency and/or borderline sweat test values were carrying rare haplotypes on their CF chromosomes. Adult patients clustered in genotype groups with normal height percentile distributions. This association between haplotype and clinical severity of CF in the German population provides evidence for genetic microheterogeneity of the CF locus, either because of the existence of multiple alleles of the CF gene itself and/or because of the existence of closely linked polymorphic genes that control growth and development and hence modulate the clinical course and prognosis of CF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968035     DOI: 10.1007/bf00200573

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  32 in total

1.  A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7.

Authors:  R G Knowlton; O Cohen-Haguenauer; N Van Cong; J Frézal; V A Brown; D Barker; J C Braman; J W Schumm; L C Tsui; M Buchwald
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

2.  Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus.

Authors:  E Kerem; M Corey; B Kerem; P Durie; L C Tsui; H Levison
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

3.  Unusual segregation of cystic fibrosis alleles.

Authors:  A Kitzis; J C Chomel; A Haliassos; L Tesson; J C Kaplan; J Feingold; G Giraud; A Lable; B Dastugue; V Dumur
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

4.  Tracing the mutations in cystic fibrosis by means of closely linked DNA markers.

Authors:  L C Tsui
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

5.  Linkage relationships and allelic associations of the cystic fibrosis locus and four marker loci.

Authors:  J Schmidtke; M Krawczak; M Schwartz; M Alkan; M Bonduelle; E Bühler; M Chemke; T Darnedde; J Domagk; W Engel
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

6.  Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.

Authors:  N Høiby; K Rosendal
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-06

7.  Cystic fibrosis: typing 48 German families with linked DNA probes.

Authors:  L Mathy; W Kampmann; M Higuchi; G Schwartenbeck; K Bartholomé; A J Driesel; K H Grzeschik; K Olek
Journal:  Hum Genet       Date:  1987-04       Impact factor: 4.132

8.  Genetic differences between cystic fibrosis with and without meconium ileus.

Authors:  E Mornet; B Simon-Bouy; J L Serre; X Estivill; M Farrall; R Williamson; J Boue; A Boue
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

9.  Localization of cystic fibrosis locus to human chromosome 7cen-q22.

Authors:  B J Wainwright; P J Scambler; J Schmidtke; E A Watson; H Y Law; M Farrall; H J Cooke; H Eiberg; R Williamson
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

10.  [Cystic fibrosis: long-term treatment at a specialized centre, and its prognostic value (author's transl)].

Authors:  B Tümmler; H von der Hardt; W Müller; C Rieger
Journal:  Monatsschr Kinderheilkd       Date:  1982-03       Impact factor: 0.323

View more
  3 in total

1.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

2.  Perspectives of longitudinal growth in cystic fibrosis from birth to adult age.

Authors:  G Haeusler; H Frisch; T Waldhör; M Götz
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

3.  The origin of Eastern European Jews revealed by autosomal, sex chromosomal and mtDNA polymorphisms.

Authors:  Avshalom Zoossmann-Diskin
Journal:  Biol Direct       Date:  2010-10-06       Impact factor: 4.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.